432 related items for PubMed ID: 9521938
1. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.
Therrell BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S.
Pediatrics; 1998 Apr; 101(4 Pt 1):583-90. PubMed ID: 9521938
[Abstract] [Full Text] [Related]
2. Effect of newborn screening for congenital adrenal hyperplasia.
Brosnan PG, Brosnan CA, Kemp SF, Domek DB, Jelley DH, Blackett PR, Riley WJ.
Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1272-8. PubMed ID: 10591305
[Abstract] [Full Text] [Related]
3. Newborn screening for congenital adrenal hyperplasia.
Therrell BL.
Endocrinol Metab Clin North Am; 2001 Mar; 30(1):15-30. PubMed ID: 11344933
[Abstract] [Full Text] [Related]
4. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM.
BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810
[Abstract] [Full Text] [Related]
5. Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states.
Held PK, Shapira SK, Hinton CF, Jones E, Hannon WH, Ojodu J.
Mol Genet Metab; 2015 Nov 17; 116(3):133-8. PubMed ID: 26296712
[Abstract] [Full Text] [Related]
6. A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas.
Brosnan CA, Brosnan P, Therrell BL, Slater CH, Swint JM, Annegers JF, Riley WJ.
Public Health Rep; 1998 Nov 17; 113(2):170-8. PubMed ID: 9719819
[Abstract] [Full Text] [Related]
7. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, Zappulla F.
Pediatrics; 1996 Sep 17; 98(3 Pt 1):362-7. PubMed ID: 8784357
[Abstract] [Full Text] [Related]
8. Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study.
Gidlöf S, Wedell A, Guthenberg C, von Döbeln U, Nordenström A.
JAMA Pediatr; 2014 Jun 17; 168(6):567-74. PubMed ID: 24733564
[Abstract] [Full Text] [Related]
9. Ten-year evaluation of a Neonatal Screening Program for congenital adrenal hyperplasia.
Nascimento ML, Cristiano AN, Campos Td, Ohira M, Cechinel E, Simoni G, Lee Jv, Linhares RM, Silva PC.
Arq Bras Endocrinol Metabol; 2014 Oct 17; 58(7):765-71. PubMed ID: 25372587
[Abstract] [Full Text] [Related]
10. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.
Thil'en A, Nordenström A, Hagenfeldt L, von Döbeln U, Guthenberg C, Larsson A.
Pediatrics; 1998 Apr 17; 101(4):E11. PubMed ID: 9521977
[Abstract] [Full Text] [Related]
11. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
Güran T, Tezel B, Gürbüz F, Selver Eklioğlu B, Hatipoğlu N, Kara C, Şimşek E, Çizmecioğlu FM, Ozon A, Baş F, Aydın M, Darendeliler F.
J Clin Res Pediatr Endocrinol; 2019 Feb 20; 11(1):13-23. PubMed ID: 30111524
[Abstract] [Full Text] [Related]
12. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing.
Gong LF, Gao X, Yang N, Zhao JQ, Yang HH, Kong YY.
J Pediatr Endocrinol Metab; 2019 Mar 26; 32(3):253-258. PubMed ID: 30817302
[Abstract] [Full Text] [Related]
13. Outcome of Newborn Screening for Congenital Adrenal Hyperplasia at Two Time Points.
Eshragh N, Doan LV, Connelly KJ, Denniston S, Willis S, LaFranchi SH.
Horm Res Paediatr; 2020 Mar 26; 93(2):128-136. PubMed ID: 32659761
[Abstract] [Full Text] [Related]
14. A three-year follow-up of congenital adrenal hyperplasia newborn screening.
Pezzuti IL, Barra CB, Mantovani RM, Januário JN, Silva IN.
J Pediatr (Rio J); 2014 Mar 26; 90(3):300-7. PubMed ID: 24560529
[Abstract] [Full Text] [Related]
15. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
Nordenström A, Wedell A, Hagenfeldt L, Marcus C, Larsson A.
Pediatrics; 2001 Oct 26; 108(4):E68. PubMed ID: 11581476
[Abstract] [Full Text] [Related]
16. [Congenital adrenal hyperplasia].
Stanić M, Nesović M.
Med Pregl; 1999 Oct 26; 52(11-12):447-54. PubMed ID: 10748766
[Abstract] [Full Text] [Related]
17. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
Varness TS, Allen DB, Hoffman GL.
J Pediatr; 2005 Oct 26; 147(4):493-8. PubMed ID: 16227036
[Abstract] [Full Text] [Related]
18. Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation.
Kopacek C, Prado MJ, da Silva CMD, de Castro SM, Beltrão LA, Vargas PR, Grandi T, Rossetti MLR, Spritzer PM.
J Pediatr (Rio J); 2019 Oct 26; 95(3):282-290. PubMed ID: 29715434
[Abstract] [Full Text] [Related]
19. Neonatal screening for congenital adrenal hyperplasia: experience and results in Argentina.
Gruñieiro-Papendieck L, Chiesa A, Mendez V, Prieto L.
J Pediatr Endocrinol Metab; 2008 Jan 26; 21(1):73-8. PubMed ID: 18404975
[Abstract] [Full Text] [Related]
20. High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland.
Steigert M, Schoenle EJ, Biason-Lauber A, Torresani T.
J Clin Endocrinol Metab; 2002 Sep 26; 87(9):4106-10. PubMed ID: 12213856
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
